Algorithmic fairness in artificial intelligence for medicine and healthcare

RJ Chen, JJ Wang, DFK Williamson, TY Chen… - Nature biomedical …, 2023 - nature.com
In healthcare, the development and deployment of insufficiently fair systems of artificial
intelligence (AI) can undermine the delivery of equitable care. Assessments of AI models …

Demographic bias in misdiagnosis by computational pathology models

A Vaidya, RJ Chen, DFK Williamson, AH Song… - Nature Medicine, 2024 - nature.com
Despite increasing numbers of regulatory approvals, deep learning-based computational
pathology systems often overlook the impact of demographic factors on performance …

Triple negative breast cancer: molecular subtype-specific immune landscapes with therapeutic implications

A Syrnioti, S Petousis, LA Newman… - Cancers, 2024 - mdpi.com
Simple Summary Triple Negative Breast Cancer (TNBC) comprises approximately 15–20%
of all breast cancer (BC) cases, is often diagnosed at an advanced stage, and is generally …

Breast cancer statistics 2024

AN Giaquinto, H Sung, LA Newman… - CA: a cancer journal …, 2024 - Wiley Online Library
Abstract This is the American Cancer Society's biennial update of statistics on breast cancer
among women based on high‐quality incidence and mortality data from the National Cancer …

[HTML][HTML] Tumor sequencing of African ancestry reveals differences in clinically relevant alterations across common cancers

E Jiagge, DX **, JY Newberg, T Perea-Chamblee… - Cancer Cell, 2023 - cell.com
Cancer genomes from patients with African (AFR) ancestry have been poorly studied in
clinical research. We leverage two large genomic cohorts to investigate the relationship …

Age at diagnosis for lung, colon, breast and prostate cancers: An international comparative study

H Zahed, X Feng, M Sheikh, F Bray… - … journal of cancer, 2024 - Wiley Online Library
Differences in the average age at cancer diagnosis are observed across countries. We
therefore aimed to assess international variation in the median age at diagnosis of common …

Combination of dual JAK/HDAC inhibitor with regorafenib synergistically reduces tumor growth, metastasis, and regorafenib-induced toxicity in colorectal cancer

P Bajpai, S Agarwal, F Afaq, S Al Diffalha… - Journal of Experimental …, 2024 - Springer
Background Treatment with regorafenib, a multiple-kinase inhibitor, to manage metastatic
colorectal cancers (mCRCs) shows a modest improvement in overall survival but is …

Single-nucleus chromatin accessibility and transcriptomic map of breast tissues of women of diverse genetic ancestry

P Bhat-Nakshatri, H Gao, AS Khatpe, AK Adebayo… - Nature Medicine, 2024 - nature.com
Single-nucleus analysis allows robust cell-type classification and helps to establish
relationships between chromatin accessibility and cell-type-specific gene expression. Here …

Genomic landscape of cancer in racially and ethnically diverse populations

CE Thomas, U Peters - Nature Reviews Genetics, 2024 - nature.com
Cancer incidence and mortality rates can vary widely among different racial and ethnic
groups, attributed to a complex interplay of genetic, environmental and social factors …

Stromal heterogeneity may explain increased incidence of metaplastic breast cancer in women of African descent

B Kumar, AS Khatpe, J Guanglong, K Batic… - Nature …, 2023 - nature.com
The biologic basis of genetic ancestry-dependent variability in disease incidence and
outcome is just beginning to be explored. We recently reported enrichment of a population of …